BDBM160170 US9040663, 16

SMILES COc1ccc(C[C@H]2NC(=O)[C@H](CCN)NC(=O)[C@H](CCC(=O)NCCC[C@H](NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)cc1

InChI Key

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 160170   

TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160170(US9040663, 16)
Affinity DataKi:  0.150nM ΔG°:  -13.9kcal/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160170(US9040663, 16)
Affinity DataKi:  0.25nM ΔG°:  -13.6kcal/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent